Skip to main content
Sharda Cropchem Limited logo

Sharda Cropchem Limited — Investor Relations & Filings

Ticker · SHARDACROP ISIN · INE221J01015 LEI · 335800D6YDEC9V93VC08 BSE.NS Manufacturing
Open in API
Filings indexed 700 across all filing types
Latest filing 2026-05-19 Call Transcript
Country IN India
Listing BSE.NS SHARDACROP

About Sharda Cropchem Limited

https://shardacropchem.com/

Sharda Cropchem Limited is a global provider of crop protection products and industrial goods, operating under an asset-light business model. The company specializes in the identification of generic molecules, the preparation of technical dossiers, and the acquisition of product registrations in international markets. Its core agricultural portfolio includes herbicides, fungicides, and insecticides designed to enhance crop yields. Additionally, the company operates a non-agrochemical division focused on industrial products such as conveyor belts, V-belts, and specialty chemicals. By outsourcing manufacturing to third-party producers and focusing on intellectual property and regulatory compliance, the company maintains a flexible supply chain. Sharda Cropchem serves an extensive distribution network spanning Europe, NAFTA, Latin America, and other global regions, emphasizing a strong pipeline of registrations as a key competitive advantage.

Recent filings

Filing Released Lang Actions
Earnings Call Transcript of the conference call held on 14th May 2026.
Call Transcript Classification · 92% confidence The document is a complete transcript of Sharda Cropchem Limited’s Q4 FY2025-26 earnings conference call, including participant Q&A. It was filed under Regulation 30 of the SEBI LODR and contains the full text of the call session. This matches the definition of a Call Transcript (CT).
2026-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Sharda Cropchem Limited for Q4 FY 2025-26. It includes management commentary on financial results, detailed discussion of revenue, EBITDA, PAT, segmental performance, and outlook for the next fiscal year. The text contains a Q&A session with analysts and investors, which is typical of earnings call transcripts. The document is not a brief announcement or a summary but a full transcript of the call, including management remarks and Q&A. Therefore, it fits the category of a Call Transcript (CT).
2026-05-19 English
Intimation of Schedule of Analyst / Institutional Investor Meeting
Regulatory Filings Classification · 95% confidence The document is a statutory announcement to stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30(6), disclosing the schedule of analyst/institutional investor meetings. It does not contain financial statements or substantive report content, nor does it present executive changes, dividends, or capital transactions. It is a routine regulatory disclosure, best classified under general Regulatory Filings (RNS).
2026-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an exchange filing notifying the schedule for analyst and institutional investor meetings under SEBI LODR Regulation 30. It does not contain financial data or a report, nor is it an earnings release or a management discussion. It’s a general regulatory announcement required for compliance. Therefore, it falls under the catch-all “Regulatory Filings” category (RNS).
2026-05-18 English
Annual Secretarial Compliance Report for the financial year ended 31st March 2026.
Regulatory Filings Classification · 91% confidence The document is a letter to stock exchanges submitting the “Annual Secretarial Compliance Report” for the year ended March 31, 2026. It is a statutory compliance certificate prepared by the company secretary and practising firm under SEBI LODR Regulation 24A, comprising attestations of regulatory filings, corporate governance and secretarial standards compliance. It does not contain financial statements or operate as an annual or interim report; rather it is a regulatory/secretarial compliance filing. Under the certification rule, such officer attestation letters and compliance reports are classified as Regulatory Filings (RNS).
2026-05-14 English
Audio Recording of Earnings Call Q4 FY 2025-26.
Report Publication Announcement Classification · 85% confidence The document is a short Regulation 30 disclosure to stock exchanges announcing that the audio link for the Q4 FY 2025-26 earnings conference call is now available on the company’s website. It does not contain financial results or a transcript but merely informs of the publication of the audio “report.” This fits the definition of a Report Publication Announcement (RPA).
2026-05-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.